MIAMI, Oct. 03, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 63rd Emerging Growth Conference on October 4th and 5th, 2023.
The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.
Register for the conference here.
Submit Questions for any of the presenting companies to:
This email address is being protected from spambots. You need JavaScript enabled to view it.
For updates, follow us on Twitter
Day 1
October 4, 2023
8:45
Virtual Lobby opens.
Register for the Conference. If you already registered, go back to the registration link and click “Already registered” and enter your email.
9:00
Introduction
9:05 - 9:35
AGBA Group Holding Limited (NASDAQ: AGBA)
Mr. Wing-Fai Ng, Group President of AGBA Group
9:40 - 10:10
Loop Industries, Inc. (NASDAQ: LOOP)
Kevin C. O’Dowd, VP Communications
10:15 - 10:45
CoTec Holdings Corp. (OTCQB: CTHCF) (TSXV: CTH)
Julian Treger, President / CEO
10:50 - 11:20
ASP Isotopes, Inc. (NASDAQ: ASPI)
Paul Elliot Mann, CEO
11:25 - 11:55
Akari Therapeutics, plc (NASDAQ: AKTX)
Rachelle Jacques, CEO
12:00 - 12:30
FendX Technologies, Inc. (OTCQB: FDXTF) (CSE: FNDX)
Carolyn Jane Myers, CEO
1:10 - 1:40
NeuroSense Therapeutics, Ltd. (NASDAQ: NRSN)
Alon Ben-Noon, Co-Founder, CEO & Director
Postponed to November 1, 2023
Coeptis Therapeutics Holdings, Inc., (NASDAQ: COEP)
David Mehalick, President / CEO
2:55 - 3:05
Rakovina Therapeutics Inc. (TSXV: RKV)
Jeffrey Bacha, Executive Chairman & David Hyman, President
3:10 - 3:20
Alpha Tau Medical, Inc. (NASDAQ: DRTS)
Raphi Levy, CFO
3:25 - 3:35
GeoVax Labs, Inc. (NASDAQ: GOVX)
David Dodd, Chairman, President / CEO
3:40 - 3:50
Renforth Resources, Inc. (OTCQB: RFHRF) (CSE: RFR)
Nicole Brewster, President & CEO
3:55 - 4:05
NeuroMetrix, Inc. (NASDAQ: NURO)
Dr. Shai Gozani, CEO & Thomas Higgins, CFO
Day 2
October 5, 2023
9:00
Virtual Lobby opens.
Register for the Conference. If you already registered, go back to the registration link and click “Already registered” and enter your email.
9:35
Introduction
9:40 - 10:10
Theriva Biologics (NYSE American: TOVX)
Steven A. Shallcross, CEO / CFO
10:15 - 10:45
Bioxytran, Inc. (OTCQB: BIXT)
Mike Sheikh, Executive Vice President Business Development
10:50 - 11:20
Inspire Veterinary Partners, Inc. (NASDAQ: IVP)
Kimball Carr, Chairman, President & CEO
12:00 - 12:30
BioLargo, Inc. (OTCQB: BLGO)
Dennis Calvert, President / CEO
1:10 - 1:40
Nextech3D.ai, formerly known as “Nextech AR Solutions Corp” (OTCQX: NEXCF) (CSE: NTAR) (FSE: EP2)
Evan Gappelberg, CEO
1:45 - 2:15
Sokoman Minerals Corp., (OTCQB: SICNF) (TSXV: SIC)
Timothy Froude P. Geo. CEO, Pres & Director
2:20 - 2:50
Knightscope, Inc. (NASDAQ: KSCP)
William Santana Li Chairman & CEO
2:55 - 3:05
Cyngn, Inc. (NASDAQ: CYN)
Lior Tal, CEO & Director
3:10 - 3:20
Citizens, Inc. (NYSE: CIA)
Gerald W. Shields, Vice Chairman / CEO, & Jeff Conklin, CFO
3:25 - 3:35
Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE)
Michael Martino, CEO & Director
3:40 - 3:50
Steppe Gold, Ltd. (OTCQX: STPGF) (TSX: STGO)
Aneel Singh, Exec. VP & Director
3:55 – 4:05
Regen Biopharma, Inc. (OTC Pink: RGBP)
David Koos, President / CEO
Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.
Register for the conference here.
Submit Questions for any of the presenting companies to:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Replays: Subscribe to our YouTube Channel
About EmergingGrowth.com
Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.
About the Emerging Growth Conference
The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.
All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on www.EmergingGrowth.com.
If you believe or know of a company that might fit our audience, contact us here.
Thank you for your interest in our conference, and we look forward to your participation in future conferences.
Contact:
Emerging Growth
Phone: 1-305-330-1985
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$2.08 |
Daily Change: | -0.15 -6.73 |
Daily Volume: | 19,446 |
Market Cap: | US$25.250M |
November 08, 2024 August 19, 2024 August 19, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB